|
Safety and efficacy of preoperative thienopyridines in the ACUITY Trial |
Dr. Ramin Ebrahimi discusses the implications of preoperative thienopyridine use prior to coronary bypass graft surgery in patients with ACS: A report from the ACUITY Trial
Sponsorship for the booth and interviews at ACC 2007 was provided by the Center for Health Education (CHE) through unrestricted joint educational grants from the Medicines Company, Merck, Schering-Plough and Scios.
[ Download video ] |
|
No comments have been submitted
|